Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a meta-analysis
Open Access
- 8 March 2024
- journal article
- review article
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-15
Abstract
The global impact of SARS-CoV-2 infection has raised concerns about secondary diseases beyond acute illness. This review explores the significance and potential underlying mechanisms of how SARS-CoV-2 infection might elicit an immune response targeting N-methyl-D-aspartate (NMDA) receptors, and its implications for autoimmune-driven neuropsychiatric manifestations. We identified 19 published case reports of NMDA receptor encephalitis associated with SARS-CoV-2 infection or vaccination by a systematic literature search. The significance of these reports was limited since it is not clear if a coincidental or causal relationship exists between SARS-CoV-2 infection or vaccination and manifestation of NMDA receptor encephalitis. The included studies were hampered by difficulties in establishing if these patients had pre-existing NMDA receptor antibodies which entered the brain by infection- or vaccination-associated transient blood-brain barrier leakage. In addition, four cases had comorbid ovarian teratoma, which is a known trigger for development of NMDA receptor encephalitis. Considering that billions of people have contracted COVID-19 or have been vaccinated against this virus, the publication of only 19 case reports with a possible link to NMDA receptor encephalitis, indicates that it is rare. In conclusion, these findings do not support the case that SARS-CoV-2 infection or vaccination led to an increase of existing or de novo encephalitis mediated by an autoimmune response targeting NMDA receptor function. Nevertheless, this work underscores the importance of ongoing vigilance in monitoring viral outbreaks and their potential impact on the central nervous system through basic, epidemiological and translational research.Keywords
Funding Information
- European Research Area Network (ERA-NET) NEURON “Translational Biomarkers in Brain Disorders”
This publication has 101 references indexed in Scilit:
- COVID-19 and Risk for Mental Disorders Among Adults in DenmarkJAMA Psychiatry, 2023
- Psychological Distress Impact of Coronavirus Disease (COVID-19) Outbreak on Three Continents: A Systematic Review and Meta-analysis2023
- Overview of autoantibodies in COVID‐19 convalescentsJournal of Medical Virology, 2023
- COVID‐19 as a trigger of Guillain‐Barré syndrome: A review of the molecular mechanismImmunity, Inflammation and Disease, 2023
- Changes in the Rate of Leucine-Rich Glioma-Inactivated 1 Seropositivity During the COVID-19 LockdownJAMA Neurology, 2023
- Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 IllnessJAMA Psychiatry, 2022
- The impact of COVID‐19 lockdown on brain metabolismHuman Brain Mapping, 2021
- Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”Annals of Clinical and Translational Neurology, 2021
- A Survey of Psychological Distress Among the Community in the COVID-19 Epidemic: A Cross-Sectional Study2021
- Molecular mimicry: a critical look at exemplary instances in human diseasesCellular and Molecular Life Sciences, 2000